NCT00166465View on ClinicalTrials.gov

Stage IV Colorectal CA ALIMTA

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions

Locally Advanced Unresectable or Stage IV Colorectal Cancer

Interventions

DRUG

ALIMTA plus Oxaliplatin versus Oxaliplatin plus 5-Fluorouracil and Leucovorin (FOLFOX 4 Regimen)

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER